National Institute for Health and Care Excellence

A part of the National Health Service, also called NICE

Before 1st April 2013, NICE was called the National Institute for Health and Clinical Excellence.

79 requests
Make a request to this authority
Haemotherapy
Request sent to National Institute for Health and Care Excellence by michael price on .

Awaiting response.

What forms of Haemotherapy are legally allowed in the UK? What forms of Haemotherapy are used by the NHS? The search term haemotherapy does not a...
Redacted information in NICE appraisal: Sodium zirconium cyclosilicate for treating hyperkalaemia [ID1293]
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Withdrawn by the requester.

Dear Till,   Reference No: EH99354   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 5 December 2018, i...
Redacted information in NICE appraisal: STA Palbociclib
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Awaiting response.

Dear Till,   Reference No: EH99324   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 5 December 2018, i...
Redacted information in NICE appraisal: Sodium Zirconium Cyclosilicate
Request sent to National Institute for Health and Care Excellence by Till Bruckner on .

Awaiting response.

according to the Agreement between the Association of the British Pharmaceutical Industry (ABPI) and the National Institute for Health and Clinical...
CBT and NLP
Response by National Institute for Health and Care Excellence to Ian Couling on .

Successful.

Dear Ian   Reference No: EH57605   FREEDOM OF INFORMATION ACT 2000   Thank you for your request for information, received at this office on...
Information on changes made to Interactions Information on your web site
Response by National Institute for Health and Care Excellence to Spencer on .

Awaiting classification.

Dear Spencer,   Reference No: EH96888   FREEDOM OF INFORMATION ACT 2000   On 21 September 2018, you asked NICE for information relating to...
Olazapine v Risperidone information pre and post interaction changes
Response by National Institute for Health and Care Excellence to Spencer on .

Awaiting classification.

Dear Spencer,   Reference No: EH96889   FREEDOM OF INFORMATION ACT 2000   On 21 September 2018, you asked NICE for information relating to...
Clinical guidance for polypropylene mesh implants for incontinence and prolapse under SERNIP and then NICE
Response by National Institute for Health and Care Excellence to kath sansom on .

Awaiting classification.

Dear Ms Sansom,   Reference No: EH95323   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 28 July 2018,...
Multiple Myeloma: how is QALY assessed?
Response by National Institute for Health and Care Excellence to Jane Finbow on .

Awaiting classification.

Dear Jane,   Reference No: EH95336   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 30 July 2018, in w...
Audit and decision aid tool based on NICE recommendations: who is building it, and how was it commissioned?
Response by National Institute for Health and Care Excellence to Ben Goldacre on .

Successful.

Dear Ben   Reference No: EH94624   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 6 July 2018. Please...
Protocols for SACT studies for drugs and indications in the Cancer Drugs Fund
Response by National Institute for Health and Care Excellence to Helen Macdonald on .

Partially successful.

Dear Helen I can confirm that the DCA gives an overview of the data that will be collected. The sponsor (typically a pharmaceutical company) will hol...
Directives regarding FQ safety
Response by National Institute for Health and Care Excellence to Richard Glassberg on .

Awaiting classification.

Dear Mr Glassberg,   Reference No: EH95722   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 11 August...
What is the ratio of men needing knee replacement to women between the age of 55 & 65 and what is the reason for this?
Response by National Institute for Health and Care Excellence to Trudy Baddams on .

Long overdue.

Dear Trudy   Reference No: EH95231   FREEDOM OF INFORMATION ACT 2000   Thank you for your request for information, received at this office...
Clinical trial data used by NICE in its palbociclib (Ibrance) assessment
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Successful.

Dear Till,   Reference No: EH92868   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 14 May 2018, in wh...
Minutes of Meetings - Thyroid Guideline Committee
Response by National Institute for Health and Care Excellence to Linda Sanday on .

Successful.

  Dear Linda,   Thank you for your request, sent to our office on 7 June 2018, in which you asked NICE for the information related to the [1]gui...
Attendance at meeting with Vertex Pharmaceuticals on 25th May 2018
Response by National Institute for Health and Care Excellence to Mr Burn on .

Successful.

Dear Mr Burn,   Reference No: EH93308   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 27 May 2018, in...
SSRI Interventions in Social Phobia and Depression
Response by National Institute for Health and Care Excellence to Adam Daley on .

Partially successful.

Dear Mr Daley,   Reference No: EH74189   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 17 October 201...
Prescribing Criteria Resources In Relation To Alzheimer’s Dementia Patients Suffering From Asbestos Mesothelioma Perscribed Diease
Response by National Institute for Health and Care Excellence to dennis on .

Long overdue.

Dear Mr Martin,   Reference No: EH90501   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 2 March 2018,...
Basis of calculations for economic effectiveness of water fluoridation
Response by National Institute for Health and Care Excellence to Joy Warren on .

Information not held.

Dear Ms Warren,   Reference No: EH90279   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 24 February 2...
Needle and syringe exchange statistics
Response by National Institute for Health and Care Excellence to Aneesa Anwar on .

Information not held.

Dear Aneesa,   Reference No: EH90287   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 25 February 2018...
Tests on Aspirin
Response by National Institute for Health and Care Excellence to Olly H on .

Information not held.

Dear Olly,   Reference No: EH87915   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 17 December 2017,...
Lyme disease guidelines
Response by National Institute for Health and Care Excellence to Claire Sidwell on .

Awaiting classification.

  Dear Ms Sidwell,   Reference No: EH88945   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 20 Janua...
Lobbying by Pharmaceutical Companies
Response by National Institute for Health and Care Excellence to Philip Deans on .

Successful.

Dear P Deans,      Our reference No: EH68998   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 22 April...
Use of benzodiazepines
Response by National Institute for Health and Care Excellence to Philip Deans on .

Successful.

Dear Philip,   Our reference No: EH69783   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 19 May 2016,...
NICE Guideline development group, for Lyme Disease (borreliosis)[GID-NG10007], GDG committee member Kieran Hand communications
Response by National Institute for Health and Care Excellence to Peter Kemp on .

Successful.

Dear Peter,  Our reference No: EH85415 FREEDOM OF INFORMATION ACT 2000 Thank you for your Freedom of Information request, sent to our office on 4...

Only requests made using WhatDoTheyKnow are shown. ?